Bevacizumab and Sinus Venous Thrombosis: A Literature Review

Pediatric glioma treatment can be confounded by eloquent anatomical location and pathologic and genetic characteristics. Current literature suggests that the vascular endothelial growth factor (VEGF) inhibitor bevacizumab has been linked to enhancing disease control; however, its safety and effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Vikash, Jain, Esha, Hitawala, Gazala, Loh, Hanyou, Patel, Suyog, Thada, Pawan, Nandwana, Varsha, Pandey, Shreya, Quinonez, Jonathan, Naz, Sidra, Stein, Joel D, Cueva, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665695/
https://www.ncbi.nlm.nih.gov/pubmed/34912612
http://dx.doi.org/10.7759/cureus.19471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665695/
https://www.ncbi.nlm.nih.gov/pubmed/34912612
http://dx.doi.org/10.7759/cureus.19471

Ejemplares similares